Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 18, 2021, Zoetis Inc. (the "Company") announced that Dr. Catherine
Knupp, DVM, MS, the Company's Executive Vice President and President of
Research & Development, has provided notice of her intention to retire from her
position, effective December 31, 2021, and that the Company has appointed Robert
J. Polzer, PhD, who currently serves as the Company's Senior Vice President of
Global Therapeutics, to succeed Dr. Knupp as the Company's Executive Vice
President and President of Research & Development, effective January 1, 2022.
The Company and Dr. Knupp expect Dr. Knupp to remain with the Company as an
advisor assisting with the transition of her duties from January 1, 2022 until
February 28, 2022.
Item 8.01. Other Events.
On October 18, 2021, the Company issued a press release announcing the
appointment of Dr. Polzer and the retirement of Dr. Knupp. A copy of the press
release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following Exhibits are filed herewith as part of this report:
Exhibit No. Description
99.1 Press Release dated as of October 18, 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
-2-
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses